IK and cancer: As such, this mutational process is likely to be important not only in cancers with RER deficiency, but also those with high TOP1 activity and tumours with defects in relevant repair mechanisms, such as enzymes that process TOP1cc6 or non-ligatable TOP1-induced nicks44–46.